Search Results
Taking a BiTE Out of SCLC
Recent developments in SCLC
DAREON™-9: DLL-3 BiTE + Topotecan in Small Cell Lung Cancer (SCLC) • Dr. Aman Chauhan
Facilitating Progress in the Treatment of SCLC
The DLL3-targeting BiTE, tarlatamab, for the treatment of SCLC
BI 764532: a novel T-cell engager for patients with DLL3+ SCLC and NEC
Update from a phase 1 study of AMG 757 in SCLC
The current treatment landscape for SCLC
Evaluating Tarlatamab in Recurrent Small Cell Lung Cancer Treatment
Tarlatamab: Mechanism of Action and Clinical Success in Small Cell Lung Cancer │ Pharmacology
Byeong Yoon, PhD: A New Treatment Option for ES-SCLC
How a new treatment could cure stage 4 lung cancer
